{
    "code": "56025531",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56025531",
    "time": "2019-06-28 03:09:01",
    "許可證字號": "衛部醫器輸字第025531號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/10\/21",
    "發證日期": "102\/10\/21",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA05602553108",
    "中文品名": "羅氏凡塔那抗ALK(D5F3)兔子單株抗體",
    "英文品名": "VENTANA anti-ALK(D5F3) Rabbit Monoclonal Primary Antibody",
    "效能": "本產品是預定供實驗室使用，藉以在BenchMark GX\/XT\/ULTRA 全自動免疫組織化學染色暨原位雜交染色 (IHC\/ISH) 儀上對福馬林固定、石蠟包埋的非小細胞肺癌(NSCLC)組織內的間變性淋巴瘤激酶(ALK)蛋白進行檢測。本抗體可輔助篩選適合接受XALKORI (crizotinib)、ZYKADIA (ceritinib)或ALECENSA (alectinib)治療的病患。",
    "醫器規格": "790-4794(06679072001)\r\n以下空白\r\n標籤、仿單變更為：詳如中文仿單核定本（原102年11月14日仿單標籤核定本正本收回作廢）。\r\n規格（性能宣稱）、標籤及仿單變更為：詳如中文仿單核定本（原104年8月27日仿單標籤核定本正本收回作廢）。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "主成分略述": "",
    "主製造廠": {
        "申請商名稱": "1903101100  台灣羅氏醫療診斷設備股份有限公司",
        "申請商地址": "台北市中山區民權東路3段2號10樓",
        "主製造廠": "",
        "製造廠名稱": "MUS1700000  VENTANA MEDICAL SYSTEMS, INC.",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560255310005-108-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025531&Seq=003&Type=9"
        },
        {
            "title": "560255310005-108-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025531&Seq=004&Type=8"
        }
    ]
}